|
US7731972B1
(en)
*
|
2000-02-04 |
2010-06-08 |
Vlaams Interuniversitair Instituut Voor Biotechnologie |
Immunoprotective influenza antigen and its use in vaccination
|
|
JP2001521908A
(ja)
*
|
1997-10-31 |
2001-11-13 |
シストロン バイオテクノロジー インク． |
ワクチンアジュバントとして有用な封入された免疫調節物質
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
CA2428103C
(en)
|
2000-11-07 |
2015-06-09 |
Immunovaccine Technologies Inc. |
Vaccines with enhanced immune response and methods for their preparation
|
|
AU2002236526B9
(en)
*
|
2000-11-15 |
2008-05-01 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Sol-fusin: use of GP64-6His to catalyze membrane fusion
|
|
MY134424A
(en)
*
|
2001-05-30 |
2007-12-31 |
Saechsisches Serumwerk |
Stable influenza virus preparations with low or no amount of thiomersal
|
|
CA2451091A1
(en)
*
|
2001-06-25 |
2003-01-03 |
Yissum Research Development Company Of The Hebrew University In Jerusale M |
A method for preparation of vesicles loaded with biological material and different uses thereof
|
|
EP1401492B1
(en)
*
|
2001-07-05 |
2009-05-20 |
LTB4 Sweden AB |
Ltb4 as vaccine adjuvant
|
|
US20040208920A1
(en)
*
|
2002-07-03 |
2004-10-21 |
Dov Michaeli |
Liposomal vaccine
|
|
US20040247661A1
(en)
*
|
2002-07-03 |
2004-12-09 |
Dov Michaeli |
Liposomal vaccine
|
|
US20050169979A1
(en)
*
|
2002-07-03 |
2005-08-04 |
Dov Michaeli |
Liposomal vaccine
|
|
CN1812766A
(zh)
|
2003-04-25 |
2006-08-02 |
宾州研究基金会 |
用于全身传递使生长停滞的、衍生于脂质的生物活性化合物的方法和系统
|
|
US20060286161A1
(en)
*
|
2003-05-09 |
2006-12-21 |
Steffen Panzner |
Injectable liposomal depots for delivering active ingredients
|
|
RU2390351C2
(ru)
*
|
2003-08-11 |
2010-05-27 |
Дзе Ресерч Фаундейшн Фо Макробайал Дизизес Оф Осака Юниверсити |
Вакцина против вируса гриппа для введения через слизистую и способ предотвращения гриппа
|
|
CN102172397B
(zh)
*
|
2003-08-21 |
2013-01-30 |
利普泰克有限公司 |
树突细胞的体内靶向
|
|
FR2868951B1
(fr)
*
|
2004-04-15 |
2006-07-21 |
Ethypharm Sa |
Compositions contenant ds vesicules lamellaires incorporant un principe actif peu soluble dans l'eau et produits intermediaires utiles pour leur preparation
|
|
US20050260260A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Edward Kisak |
Liposome compositions for the delivery of macromolecules
|
|
KR20070108371A
(ko)
*
|
2005-01-05 |
2007-11-09 |
필라델피아 헬스 앤드 에듀케이션 코퍼레이션 |
전달 비히클, 생물활성 물질 및 바이러스 백신
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
WO2009039628A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Immunovaccine Technologies Inc. |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
EP2231180B1
(en)
*
|
2008-01-16 |
2016-08-17 |
Ben-gurion University Of The Negev Research And Development Authority |
Vaccine for alzheimer's disease
|
|
AU2009253780B2
(en)
|
2008-06-05 |
2014-08-14 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
CA2730340C
(en)
*
|
2008-07-14 |
2017-02-07 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
US20120157419A1
(en)
|
2009-02-02 |
2012-06-21 |
Tuvia Gilat |
Methods and compositions for treating alzheimer's disease
|
|
ES2573427T3
(es)
|
2009-07-06 |
2016-06-07 |
Variation Biotechnologies Inc. |
Procedimientos para preparar vesículas y formulaciones producidas a partir de las mismas
|
|
CA2803282C
(en)
|
2009-07-06 |
2018-05-01 |
David E. Anderson |
Methods for preparing vesicles and formulations produced therefrom
|
|
AU2010272167B2
(en)
|
2009-07-14 |
2016-11-17 |
Polypid Ltd. |
Sustained-release drug carrier composition
|
|
EP2485758A1
(en)
|
2009-10-09 |
2012-08-15 |
New York Blood Center, Inc. |
Immunopotentiator-linked oligomeric influenza immunogenic compositions
|
|
CA2783001C
(en)
|
2010-01-19 |
2017-12-12 |
Polypid Ltd. |
Sustained-release nucleic acid matrix compositions
|
|
JP6119030B2
(ja)
*
|
2010-07-06 |
2017-04-26 |
ヴァリエーション バイオテクノロジーズ インコーポレイテッド |
インフルエンザを治療するための組成物及び方法
|
|
CN107296792B
(zh)
|
2011-01-13 |
2021-07-27 |
变异生物技术公司 |
囊泡及由其产生之制剂的制备方法
|
|
EP2663327A4
(en)
|
2011-01-13 |
2015-12-02 |
Variation Biotechnologies Inc |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
|
|
CA2850857C
(en)
|
2011-10-06 |
2022-07-26 |
Immunovaccine Technologies Inc. |
Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof
|
|
WO2013072768A2
(en)
|
2011-11-18 |
2013-05-23 |
Variation Biotechnologies, Inc. |
Synthetic derivatives of mpl and uses thereof
|
|
US20140356399A1
(en)
|
2012-01-12 |
2014-12-04 |
Variation Biotechnologies, Inc. |
Compositions and methods for treating viral infections
|
|
CA2894467A1
(en)
|
2012-01-27 |
2013-08-01 |
Variation Biotechnologies Inc. |
Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents
|
|
CN103736090B
(zh)
*
|
2014-01-27 |
2016-03-02 |
中国医学科学院医学生物学研究所 |
甲磺酸去铁胺佐剂及含甲磺酸去铁胺佐剂的疫苗
|
|
CN110151702A
(zh)
*
|
2019-06-24 |
2019-08-23 |
昆明医科大学 |
聚乙二醇修饰流感疫苗脂质体及其制备方法
|